676128-63-5 Usage
General Description
RSV604 is a novel and selective inhibitor of the respiratory syncytial virus (RSV) that works by targeting the viral fusion (F) protein, preventing the virus from entering host cells and replicating. RSV is a common respiratory virus that can cause serious respiratory illness, especially in young children and older adults. RSV604 has shown promising activity in preclinical studies against a broad range of RSV strains and has the potential to be an effective treatment for RSV infections. Its mechanism of action and high specificity make it a strong candidate for further development as a therapeutic agent for RSV.
Check Digit Verification of cas no
The CAS Registry Mumber 676128-63-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,1,2 and 8 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 676128-63:
(8*6)+(7*7)+(6*6)+(5*1)+(4*2)+(3*8)+(2*6)+(1*3)=185
185 % 10 = 5
So 676128-63-5 is a valid CAS Registry Number.
676128-63-5Relevant articles and documents
1,4-Benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidate
Henderson, Elisa A.,Alber, Dagmar G.,Baxter, Robert C.,Bithell, Sian K.,Budworth, Joanna,Carter, Malcolm C.,Chubb, Ann,Cockerill, G. Stuart,Dowdell, Verity C. L.,Fraser, Ian J.,Harris, Robert A.,Keegan, Sally J.,Kelsey, Richard D.,Lumley, James A.,Stables, Jeremy N.,Weerasekera, Natasha,Wilson, Lara J.,Powell, Kenneth L.
, p. 1685 - 1692 (2008/02/01)
Respiratory syncytial virus (RSV) is the cause of one-fifth of all lower respiratory tract infections worldwide and is increasingly being recognized as representing a serious threat to patient groups with poorly functioning or immature immune systems. Rac
